Multiple Sclerosis (MS) is a disease of the central nervous system where inflammation can interfere with nerve impulses within the brain, spinal cord and optic nerves. It is characterised by sclerosis, a Greek word meaning scars. These scars, more commonly known as lesions, can affect different sites within the central nervous system at different times, manifesting into a variety of signs and symptoms.
MS is one of the most common diseases of the central nervous system. It is estimated that more than 23,000 people are living with the disease in Australia and more than two million diagnosed worldwide. While there is currently no treatment to cure or stop MS, there are several disease-modifying treatment options which may help in reducing the frequency and severity of relapses in RRMS and slow down the progression of disability.
At Genzyme Australia and New Zealand, we are delivering new approaches for MS now and into the future.
To learn more about MS contact your doctor or other healthcare professional or the following associations: